<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The sera of 14 out of 48 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and four out of nine patients with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) contained complement-dependent hematopoietic inhibitory activity against allogeneic marrow progenitor cells </plain></SENT>
<SENT sid="1" pm="."><plain>Some sera with hematopoietic inhibitory activity, however, demonstrated no effect on autologous marrow progenitor cells </plain></SENT>
<SENT sid="2" pm="."><plain>Hematopoietic inhibitory activity was absorbed by pooled, packed platelets </plain></SENT>
<SENT sid="3" pm="."><plain>Serum hematopoietic inhibitory activity was present in both IgM and IgG fractions </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggested that serum hematopoietic inhibitors are alloantibodies and might be associated with graft rejection in the transplanted marrow of patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
</text></document>